Navigation Links
Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation
Date:3/13/2008

- Product Sales of $90 Million to $120 Million Expected in 2008 - Initial Results from JZP-6 Phase III Clinical Trial Expected by Year End - New Data Provided on Pipeline and Early-Stage Development Portfolio

- 2008 Financial Guidance Provided

PALO ALTO, Calif., March 13 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today provided a comprehensive update on its commercial activities and near-term product development pipeline, and provided 2008 financial guidance, for investors and analysts at its Investor Day meeting in New York City.

"Jazz Pharmaceuticals' strategy combines a strong commercial presence with a rapidly advancing product development pipeline addressing important patient needs in neurological and psychiatric disorders," said Samuel R. Saks, M.D., Chief Executive Officer. "With the anticipated launch of LUVOX CR later this month, continued strong performance from our XYREM sales efforts, top-line results from our first Phase III clinical study of JZP-6 for fibromyalgia syndrome and progress across our R&D portfolio, 2008 is positioned to be a transformational year for Jazz Pharmaceuticals."

Commercial Updates

Jazz Pharmaceuticals expects to launch once daily LUVOX(R) CR (fluvoxamine maleate) Extended-Release Capsules with shipments to wholesalers by the end of March. The product was approved by the U.S. Food and Drug Administration (FDA) on February 28, 2008 for the treatment of obsessive compulsive disorder (OCD) and social anxiety disorder (SAD). LUVOX CR will be priced to wholesalers at $3.25 per capsule for 100 mg and 150 mg strengths. Ex-factory sales of LUVOX CR are expected to be in the range of $40 million to $60 million during 2008.


'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
2. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
3. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
4. Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies
5. Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008
6. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
7. Jazz Pharmaceuticals, Inc. Announces Submission of Complete Response to FDA Approvable Letter for LUVOX(R) CR
8. Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
9. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
10. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
11. American Stock Exchange LLC to Delist Securities of Samaritan Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Dr. Henry H. Ting, a nationally recognized ... appointed senior vice president and chief quality officer at ... role, he will oversee the hospital's clinical quality and ... quality initiatives and interprofessional teams at the local, regional ... Door-to-Balloon Alliance, a collaboration of more than 1,000 hospitals ...
(Date:7/24/2014)... breast tumors, exposure to dim light at night made ... according to data published in Cancer Research , ... The negative effects of dim light exposure on tamoxifen ... during the night. , "Resistance to tamoxifen is a ... said Steven M. Hill, PhD, professor of structural and ...
(Date:7/24/2014)... 25, 2014 Voted one of the ... global clients, BellasDress focuses on providing its new and ... information. Recently, the company has announced its new collection ... new range is created according to the latest fashion ... up to 68% off. , As a matter of ...
(Date:7/24/2014)... The report, “Content Delivery Networks (CDN) Market”, defines ... with an in-depth analysis and forecasting of revenues. ... this market with insights on trends, opportunities, and ... 36 figures spread through 157 pages and in-depth ... http://www.marketsandmarkets.com/Market-Reports/content-delivery-networks-cdn-market-657.html . , Early buyers will ...
(Date:7/24/2014)... July 24, 2014 Just as fitness ... must consider their own financial and marketing strength to ... marketing campaigns to the next level by using the ... Center, IVR, Voice Broadcast, Call Tracking and SMS ... open rate, text messages are quickly become integral in ...
Breaking Medicine News(10 mins):Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 2Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 3Health News:Exposure to dim light at night may make breast cancers resistant to tamoxifen 2Health News:BellasDress Helps Brides Get High End Wedding Dresses for Their Romantic Weddings 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 3Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 2Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 3
... Short-course (DOTS) tuberculosis control programme will cover the entire country ... here Sunday.//, ,"The drugs for the DOTS programme will ... remote areas," said the minister at a function here to ... ,The facility has come up at the Tuberculosis Research ...
... In China people's attitudes toward sex has completely changed. Chinese ... (LAT). In this one can life the life of a ... does not desires to stay together and that the partner ... agreement includes that neither of them is obliged to have ...
... out that babies breastfed for six months have reduced ... research was conducted by investigators at UC Davis Children's ... of Pediatrics, Center for Child Health Research. ... UC Davis Children's Hospital, lead author, "We found that ...
... 'dead regions' in the brain that could be responsible ... Karolina Kluk, a Cambridge University student. // The finding ... aids for children. ,The currently available methods ... a range of tones or bleeps. This however, cannot ...
... birth control patch are twice as likely to develop clots in ... Recently, another study conducted on similar grounds // has revealed that ... women who use the patch have been urged to discus their ... ,Women who use the patch may be at an increased risk ...
... clinical trial of administering xenon gas to patients undergoing ... safe from // the brain damage that occurs post ... xenon gas to 12 patients undergoing CABG on cardiopulmonary ... treat patients suffering from strokes in whom brain damage ...
Cached Medicine News:Health News:Sex a commonplace in Chinese life 2Health News:New Test Offers Hope in Effective Hearing Aid Design for Babies 2Health News:Xenon Could Limit Nerve Damage After Stroke 2
(Date:7/24/2014)... Many new dentists who are opening their own ... their practice will be a success. DentalDisposables.net is here to ... the most can make all the difference. Dentistry is a ... that purchasing discount dental supplies can make the ... successful dentists across the United States ...
(Date:7/24/2014)... , July 24, 2014  Kinex Pharmaceuticals announced the ... the Company,s KX2-391 Ointment for the commencement of a ... the Company,s third IND to be allowed by the ... KX2-391 is a synthetic, orally active and highly selective ... KX2-391 promotes the induction of p53, G2/M arrest of ...
(Date:7/24/2014)... 2014 Research and Markets  has announced ... by Product, Component, Application and Geography - Global Forecast ... http://photos.prnewswire.com/prnh/20130307/600769 ... witness a moderate growth as the markets of the ... reached the saturation levels. The demand is expected to ...
Breaking Medicine Technology:Dental Supplies Online is Key to Dental Success...Really! 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4Machine Health Monitoring (Vibration Monitoring, Thermography, Ultrasound Emission, Lubricating Oil Analysis, Corrosion Monitoring, Motor Current Signature Analysis) Market - Forecast to 2020 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: